Physician
Oncology
Dr. Robert C. Hermann, MD
|
|
Give Review
Robert C. Hermann, MD is an expert in the field of Oncology. He graduated from University of Tennessee College of Medicine. He has 2 awards "Meaningful Use Stage 1 Certification" and "Super Doctor". Robert C. Hermann is also published. He has 16 publications published. The lastest publication: "Carmustine and Baker's antifol combination chemotherapy for primary brain tumors progressive after irradiation and chemotherapy.' Robert Hermann is registered with Medicare.
Publications
- Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.
- Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2-Negative Advanced Breast Cancer That Progressed during or after Bevacizumab.
- A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal Cancer.
- Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer.
- A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic Breast c...
- Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lu...
- Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung Cancer: results of the randomized multicenter phase III trial BMS099.
- From genetic risk awareness to overt type 1 diabetes: parental stress in a placebo-controlled prevention trial.
- Roflumilast attenuates pulmonary inflammation upon segmental endotoxin challenge in healthy subjects: a randomized placebo-controlled trial.
- TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung Cancer.
- Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
- Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase ...
- Single-agent rituximab as first-line and maintenance Treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Mi...
- Carmustine and Baker's antifol combination chemotherapy for primary Brain tumors progressive after irradiation and chemotherapy.
- Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a Myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.
Schools
Univ Of Tn Hlth Sci Ctr
Virginia Commonwealth University Medical Center
Rhodes College
Procedures Preformed
- Biological Therapy
- Biopsy
- Bone Marrow Aspiration
- Breast Cancer Treatment
- View All
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Cancer Research
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Emory University -
Virginia Commonwealth University Health System -
University of Tennessee College of Medicine
Hospital
-
Northside Hospital
Drug Facts
| NPI NUMBER | 1790789188 | |
| NPPES Provider LastName | HERMANN | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 300601121 | |
| NPPES Provider State | GA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 955.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 136.0 | |
| Percent Opioid Claims | 14.24 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790789188 |
| Last Name Of The Provider | HERMANN |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Hillary A. Hahm, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven L. McCune, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce J. Gould, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy S. McDuffie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank P. McCoy, MD
This Doctor is OpenDoctor Recommended.
|